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. On the other band, uraemic In patients with chronic renal failure, the plasma Mg 2 + plasma may a , ter Mg2 + flux across the erythrocyte concentration is increased due to reduced renal excre-membr ane. In human erythrocytes, net Mg 2 + efflux has tion, and the Mg ?+ content of erythrocytes is higher than been c haracterised äs Na^/Mg 24 " antiport (7) . Therefore, in healthy cöntrols (1)· In addition, Inhibition of Na + / we tested Na+/Mg 2 + antiport in erythrocytes from Li + antiport (2) , activatipn öf Na + /H + antiport (3), and chronic renal failure patients and in erythrocytes after increased concentration of Na" -pump-erythrocytes. ing ATPase, caused by ä substance circulating in uraemic plasma (5 "] = 0.5 mmol/1) are introduced four or five times every day into the peritoneal cavity. Toxic material and solute is continuously eliminated by diffusion and ultra filtration via the membrane of the peritoneum. All the patients with chronic renal failure had received haemodialysis or chronic ambulatory peritoneal dialysis treatment for more than 6 months.
For a better discrimination between the effect of renal disease and artificial, e. g. mechanical effects of haemodialysis, blood samples were taken from some patients (n = 4) before and after haemodialysis treatment. Furthermore, 10 former chronic renal failure patients, who had received renal transplantation more than one year previously, with subsequent good graft function (serum creatinine concentration < 200 umol/1), were included. All transplanted patients were treated with cyclosporin. As controls, blood samples from 11 healthy subjects were analysed. Erythrocytes from a control were incubated with heat-inactivated (30 min, 56 °C), üraemic plasma from seven haemodialysis patients, and with heat-inactivated homologous plasma (haematocrit: 0.50) for l, 3, 5 and 24h at 37 °C. The same ineubations were performed with the addition of 3 rnmol/1 MgCl 2 . At the end of ineubations, cells were washed twice with 150 mmol/1 NaCl and the cellular Mg 2+ content was determined äs described above.
Results

Mg
2+ concentrations in plasma and erythrocytes were significantly increased in chronic renal failure patients receiving haemodialysis and chronic ambulatory peritoneal dialysis, thus confirming published data (l, 4). In renal transplant recipients, the Mg 2+ content in plasma and erythrocytes was within the normal ränge, but lower than in controls (tab. 2).
2+ contents and rates of Na + /Mg 2+ antiport in erythrocytes of controls (tab. 2) were within the same ränge äs reported in previous studies (9) . However, Na+TMg 2 * antiport was elevated in haemodialysis patients, the mean value being three times that of controls. In chronic ambulatory peritoneal dialysis patients, Na * l 
Discussion
In chronic renal failure patient plasma, the Mg 2 * concentration was increased and almost normalised by haemodialysis (tab. 3). The increase of erythrocyte Mg 2 * is not caused by an altered activity of the Na" The difference in erythrocyte Mg 2 * content in haemodialysis and chronic ambulatory peritoneal dialysis may depend on the activity of Na*/Mg 2 * antiport. In haemodialysis, the erythrocyte Mg 2 * content was lower and the Na*/Mg 2 * antiport activity was higher than in chronic ambulatory peritoneal dialysis. The Na*/Mg 2 * antiport of normal erythrocytes was increased when they were suspended in heat-inactivated plasma from haemodialysis patients with a high Na*/Mg 2 * antiport. As the method of determination of Na*/Mg 2 * antiport requires plasma-free incubation of the erythrocytes for about 4 hours prior to measurement of transport rates, this effector must have a long lasting but reversible effect on the Na*/Mg 2 * antiporter. Düring haemodialysis, this effector is at least partly removed, leading to reduced Na*/ Mg 2 * antiport capacity (tab. 3). In vivo, however, the maximal transport capacity of Mg 2 *-loaded erythrocytes is not attained and, therefore, only a small (and insignificant) reduction of total intracellular Mg 2 * content was observed (tab. 3). Also, Na*/H* antiport, which has similar properties to Na*/Mg 2 * antiport, was increased in chronic renal failure patients (3) . A dialysable, heatstable plasma constituent with a relative molecular mass of A/ r < 3000 from chronic renal failure patients has been reported to inhibit Ca 2 * transport in normal erythrocytes (5). This effector is not identified, but possible candidates are interleukin-1, interleukin-6 and tumour necrosis factor-. It has been reported that undialysed patients with chronic renal failure and patients on haemodialysis expressed increased plasma levels of these cytokines (for references see I.e. (13)). Isolated peripheral blood mononuclear cells from chronic ambulatory peritoneal dialysis patients produced less tumour necrosis factor-than cells from haemodialysis patients (13) . However, erythrocytes do not express receptors for tumour necrosis factor-a (14) . Therefore, it is not clear whether these cytokines can directly cause the increase of Na+/Mg 2+ antiport.
An influence of urea (which accumulates to higher concentrations in patients receiving haemodialysis than in those receiving chronic ambulatory peritoneal dialysis) on the activity of Na + /Mg 2+ antiport can be excluded. In normal erythrocytes, urea concentrations up to 45 mmol/1 did not influence Na^/Mg 24 " antiport activity (data not shown).
The elevated Na + /Mg 2+ antiport in haemodialysis patients is also not caused by mechanic stress during haemodialysis, because erythrocytes which were taken immediately after the dialysis procedure even had reduced Na Increased formation of free oxygen radicals, which may occur in erythrocytes of chronic renal failure patients due to a reduction of protective enzymes (15) , can also be excluded. Free oxygen radicals have been shown to decrease rather than increase Na + /Mg 2 * aritiport in human erythrocytes (16) .
In chronic renal failure patients receivmg chronic ambulatory peritoneal dialysis, Na^/Mg 2 " 1 " antiport was not changed. Probably, this procedure is more effective in eliminating the activating plasma constituent In all chronic renal failure patients after renal transplantation, the quantities of Mg ?+ metabolism were normal, in parallel with the sufficient function of the transplanted kidney äs indicated by the plasma creatinine concentration. As all transplant recipients were treated with cyclosporin, one year after transplantätion, this drug does not seem to have an influence on erythrocyte Mg 2+ metabolism. 
